| ADIL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ADIL market cap history going back to 7/27/2018:
Also see: ADIL Shares Outstanding History and ADIL YTD Return |
ADIL Market Cap History — ADial Pharmaceuticals Capitalization Over Time
As of 5/6/2026 ADial Pharmaceuticals has a market cap of 3.39 million. Investors often follow the ADIL market cap history to compare the size of the company over time.
This page shows ADIL market capitalization trends over time, with 33 market cap datapoints presented, dating back to 7/27/2018.
| ADIL Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADIL Historical Market Cap: -23.28% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADIL Stock Price Chart |
| About ADial Pharmaceuticals Inc |
| Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development of treatments for addictions and related disorders. Co.'s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients. AD04 is investigated in the Co.'s ONWARD pivotal Phase III clinical trial for the treatment of AUD in subjects with certain target genotypes (estimated to be approximately one-third of the AUD population) identified using the Co.'s companion diagnostic genetic test. We show 33 historical shares outstanding datapoints in our ADIL shares outstanding history coverage, used to compute ADIL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADIL market cap history over the course of time is important for investors interested in comparing ADIL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ADIL versus a peer is one thing; comparing ADIL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ADIL can fluctuate over the course of history. With this page we aim to empower investors researching ADIL by allowing them to research the ADIL market cap history. |
| ADIL Current Stock Quote |
Quotes delayed 20 minutes  Free ADIL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| ADIL Share Performance |
| Market Cap Peers |
| ADial Pharmaceuticals (ADIL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ADMA Market Cap History ADMP Market Cap History ADMS Market Cap History ADPT Market Cap History ADRO Market Cap History ADTX Market Cap History ADUS Market Cap History ADVM Market Cap History ADXS Market Cap History ADYX Market Cap History More Healthcare companies » |
ADIL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
